PMGC Holdings Inc. ELAB
PMGC Holdings Inc. (Nasdaq: ELAB) is a cardio-renal-metabolic life-science company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| EL-22 | Muscle preservation in obesity treatment (with GLP-1 receptor agonists) | biologic-other | Phase 1 |
| EL-32 | Muscle preservation in obesity treatment (myostatin and activin-A) | biologic-other | Pre-clinical |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other phase 1 cardio-renal-metabolic companies
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.